Ruminant BioTech
PrivateLast Round
Grant
Feb 17, 2026
Est. Valuation
$75.3M
Total Funding Raised
$26.81M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ruminant BioTech operates in Energy & Sustainability and is based in Auckland. Its latest recorded funding round was a Series A round in November 2025.
Ruminant BioTech is an agri-tech company that develops methane mitigation solutions for cattle.
Sector
Energy & Sustainability
Verticals
Biotechnology, Carbon Capture, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ruminant BioTech Comparables
Compare Ruminant BioTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rumin8 | 86% | |
| Number 8 Bio | 86% | |
| MeTech Holdings | 81% |
For institutional investors. Book with your work email.
Ruminant BioTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2026 | ||||
| Series A | Nov 25, 2025 | ||||
| Grant | Aug 22, 2024 | ||||
| Seed | May 16, 2023 | ||||
| VC Round | Apr 6, 2023 | ||||
Grant | Nov 30, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ruminant BioTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cultivate Ventures | Series A |
| Regeneration.VC | Seed |
| Marex Group plc | Series A |
| New Zealand Green Investment Finance | Seed |
| New Zealand Government | Grant |
| Australian Government | Grant |
| Emissions Reduction Alberta | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 250% MoM, reaching 7.2K.
- May 13, 2026
Monthly visitors grew 823% MoM, from 224 to 2.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 8, 2026
AgriZeroNZ directs $5.8M into Ruminant BioTech Corp to advance an encapsulated, slow-release methane-inhibiting bolus for grazing cattle in New Zealand.
For institutional investors. Book with your work email.
Ruminant BioTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ruminant BioTech's valuation, stock price, and market status.
Is Ruminant BioTech a public or private company?
Ruminant BioTech is a private company.
What is the current stock price of Ruminant BioTech?
Ruminant BioTech is a private company, so its shares have no public market price. Caplight tracks Ruminant BioTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ruminant BioTech worth (valuation)?
Ruminant BioTech's valuation is estimated at $75.3M based on funding round data.
Can I buy Ruminant BioTech stock?
Ruminant BioTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ruminant BioTech's last funding round?
Ruminant BioTech's most recent funding round was Grant on February 17, 2026.
Who are the main investors in Ruminant BioTech?
Key investors in Ruminant BioTech include Cultivate Ventures, Regeneration.VC, AgriZeroNZ.
Will Ruminant BioTech IPO soon?
No public IPO plans have been announced for Ruminant BioTech.
How can I track Ruminant BioTech secondary market activity?
Caplight tracks bids, offers, and trades in Ruminant BioTech's shares on secondary markets.